Events

Videos

Podcasts

Articles

Hematologic Oncology

The OncLive Hematology Oncology condition center page is a comprehensive resource for clinical news and expert insights on various hematologic malignancies, including leukemias, lymphomas, myeloproliferative neoplasms, multiple myeloma, and much more. This section features news articles, interviews in written and video format, and podcasts that focus on unmet needs, treatment advances, and ongoing research in hematologic cancers.

Therapeutic Sequencing in CLL

BTK Inhibitors in Relapsed/Refractory CLL

MURANO Trial Update in R/R CLL

Utility of MRD Testing in CLL Management

Venetoclax Combinations, Safety and Efficacy

Venetoclax and Obinutuzumab in CLL

Novel Therapies for Relapsed/Refractory CLL

Relapsed/Refractory CLL: Treatment Selection

BTK inhibitor With vs Without a CD20-Targeted Antibody

Second-Generation BTK Inhibitors in CLL

Therapies in the Pipeline for Frontline CLL

Telemedicine for Patients With CLL

BTK Inhibitors in CLL: Ibrutinib

Current Role for Chemoimmunotherapy in CLL

Treating CLL During COVID-19

Frontline Treatment Options in CLL

Selecting Frontline Therapy for CLL

COVID-19 and CLL Treatment Initiation

Selecting First-Line Therapy for CLL

Advances in Frontline Therapy for CLL

 Chronic Lymphocytic Leukemia condition center page is a comprehensive resource for clinical news and expert insights on treatment advances and ongoing research in chronic lymphocytic leukemia. This page features news articles, interviews in written and video format, and podcasts that focus on unmet needs and updates with chronic lymphocytic leukemia therapy. 